Research programme: ryanodine receptor calcium release channel modulators - Australian National University/Biotron

Drug Profile

Research programme: ryanodine receptor calcium release channel modulators - Australian National University/Biotron

Alternative Names: Muscion project

Latest Information Update: 04 Feb 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Australian National University; Biotron
  • Class Peptides; Small molecules
  • Mechanism of Action Ryanodine receptor calcium release channel modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Heart failure

Most Recent Events

  • 04 Feb 2011 No development reported for Heart failure in Australia (unspecified route)
  • 27 Jun 2007 Early research in Heart failure in Australia (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top